Leo, Patrick http://orcid.org/0000-0002-2248-0610
Janowczyk, Andrew
Elliott, Robin
Janaki, Nafiseh
Bera, Kaustav http://orcid.org/0000-0001-9831-6000
Shiradkar, Rakesh http://orcid.org/0000-0003-2852-3869
Farré, Xavier http://orcid.org/0000-0001-8702-4643
Fu, Pingfu http://orcid.org/0000-0002-2334-5218
El-Fahmawi, Ayah
Shahait, Mohammed
Kim, Jessica
Lee, David http://orcid.org/0000-0003-2133-9284
Yamoah, Kosj http://orcid.org/0000-0001-9055-3538
Rebbeck, Timothy R.
Khani, Francesca http://orcid.org/0000-0001-7238-8604
Robinson, Brian D. http://orcid.org/0000-0001-5374-890X
Eklund, Lauri
Jambor, Ivan
Merisaari, Harri
Ettala, Otto
Taimen, Pekka http://orcid.org/0000-0001-8849-4604
Aronen, Hannu J.
Boström, Peter J.
Tewari, Ashutosh http://orcid.org/0000-0002-3146-4524
Magi-Galluzzi, Cristina
Klein, Eric http://orcid.org/0000-0002-1783-0698
Purysko, Andrei
NC Shih, Natalie
Feldman, Michael
Gupta, Sanjay
Lal, Priti
Madabhushi, Anant http://orcid.org/0000-0002-5741-0399
Article History
Received: 20 August 2020
Accepted: 5 April 2021
First Online: 3 May 2021
Competing interests
: A.J. has reported a consulting or advisory role with Merck. M.F. has reported consulting fees from Philips Digital Pathology. A.M. has reported being an equity holder in Elucid Bioimaging and in Inspirata Inc. In addition, he has served as a scientific advisory board member for Inspirata Inc, AstraZeneca, Bristol Meyers-Squibb, and Merck. Currently, he serves on the advisory board of Aiforia Inc. He also has sponsored research agreements with Philips, AstraZeneca, Boehringer-Ingelheim, and Bristol Meyers-Squibb. His technology has been licensed to Elucid Bioimaging. He is also involved in an NIH U24 grant with PathCore Inc, and 3 different R01 grants with Inspirata Inc. The remaining authors declare no competing interests.